Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib and Radiation for Elderly GBM
NCT01508117Phase 2Terminated
- Sponsor
- University of Cincinnati
- Start
- Aug 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in glioblastoma multiforme (GBM), sponsored by University of Cincinnati. Started Aug 2011; status: terminated.
02
Drugs
axitinib
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT01508117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01508117.